However, our perspective on these fellow members of the SAPA-GP community
quickly changed as we proceeded to interview two speakers at the conference: Drs. Ruiping Dong and Jun Wu
Our next interviewee was Dr. Jun Wu, the Chairman and founding partner of Cenova Ventures, which as the company name implies, deals with venture capital.
We met with Dr. Wu
, and the first impression we had gotten was that this man certainly had an intelligent air about him.
When we sat down for the interview, Dr. Wu
immediately dove into his
life story, using it to weave a message about career opportunities and preparing for life.
told us of the hardships he
had endured when he
first came to USA in 1987.
told us that in a month, all of his
fees and expenses added up to only $36, something that he
had described as "unimaginable for today's generation.
From there, he
was able to receive his
Ph. D. from the University of California at San Francisco
, thus beginning his
career as a Research Scientist.
However, unlike the most, he
decided to combine his
knowledge of medicine with a novel area: business.
Thus, with government and private funding, he
co-founded Shanghai Genomics
, and it grew to become one of the flagships among the Chinese biopharmaceutical companies established by returnees.
After that, he
founded Cenova Ventures
, a life science specific RMB venture fund in China.
Throughout the interview, Dr. Wu
told us about his
more sentimental values that he
holds and how his
experiences with patients of lung fibrosis inspired him to develop new medicine . Dr. Wu
then explained to us his
work on Pirfenidone, the world's 1 st anti-fibrotic drug, a potential "billion-dollar drug", developed by his
prior venture company . Dr. Wu's
story represents the power of courage and vision for changes.
Perhaps the most memorable aspect of both interviews was the mention of how life is like a net.
"In life, you study and prepare yourself for the world.
That is like knotting your net and repairing holes in the net," Dr. Wu